SC 13G/A | 2022-02-08 | FARALLON CAPITAL MANAGEMENT LLC | PROGENICS PHARMACEUTICALS INC | - | 0.0% | EDGAR |
SC 13G/A | 2021-02-16 | FARALLON CAPITAL MANAGEMENT LLC | PROGENICS PHARMACEUTICALS INC | 1,342,300 | 1.6% | EDGAR |
SC 13D/A | 2020-06-23 | Lantheus Holdings, Inc. | PROGENICS PHARMACEUTICALS INC | 1,000 | 100.0% | EDGAR |
SC 13G/A | 2020-06-04 | EAGLE ASSET MANAGEMENT INC | PROGENICS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13D | 2020-04-23 | Lantheus Holdings, Inc. | PROGENICS PHARMACEUTICALS INC | 8,011,733 | 9.3% | EDGAR |
SC 13D/A | 2020-04-15 | Altiva Management Inc. | PROGENICS PHARMACEUTICALS INC | 8,011,633 | 9.3% | EDGAR |
SC 13D/A | 2020-04-09 | Altiva Management Inc. | PROGENICS PHARMACEUTICALS INC | 8,011,633 | 9.3% | EDGAR |
SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | PROGENICS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | FARALLON CAPITAL MANAGEMENT LLC | PROGENICS PHARMACEUTICALS INC | 1,310,000 | 1.5% | EDGAR |
SC 13G | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | PROGENICS PHARMACEUTICALS INC | 4,990,790 | 5.7% | EDGAR |
SC 13G | 2020-02-13 | STATE STREET CORP | PROGENICS PHARMACEUTICALS INC | - | 5.1% | EDGAR |
SC 13G | 2020-02-11 | VANGUARD GROUP INC | PROGENICS PHARMACEUTICALS INC | 5,703,951 | 6.6% | EDGAR |
SC 13G/A | 2020-02-04 | BlackRock Inc. | PROGENICS PHARMACEUTICALS INC | 14,288,924 | 16.5% | EDGAR |
SC 13G/A | 2020-01-06 | EAGLE ASSET MANAGEMENT INC | PROGENICS PHARMACEUTICALS INC | 4,506,284 | 5.2% | EDGAR |
SC 13D/A | 2019-11-12 | Altiva Management Inc. | PROGENICS PHARMACEUTICALS INC | 8,011,733 | 9.3% | EDGAR |
SC 13D/A | 2019-09-19 | Altiva Management Inc. | PROGENICS PHARMACEUTICALS INC | 8,011,733 | 9.3% | EDGAR |
SC 13D/A | 2019-08-26 | Altiva Management Inc. | PROGENICS PHARMACEUTICALS INC | 7,418,672 | 8.6% | EDGAR |
SC 13G | 2019-06-24 | FARALLON CAPITAL MANAGEMENT LLC | PROGENICS PHARMACEUTICALS INC | 693,200 | 0.8% | EDGAR |
SC 13D/A | 2019-05-01 | Altiva Management Inc. | PROGENICS PHARMACEUTICALS INC | 6,030,000 | 7.1% | EDGAR |
SC 13D | 2019-04-05 | Altiva Management Inc. | PROGENICS PHARMACEUTICALS INC | 5,100,000 | 6.0% | EDGAR |